{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:58:18Z","timestamp":1793642298328,"version":"4.5.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["836041015"],"award-info":[{"award-number":["836041015"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","jaacap.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jaac.2020.07.888","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:01:05Z","timestamp":1595894465000},"page":"865-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5418-9791","authenticated-orcid":false,"given":"Jan J.","family":"Sprengers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6082-0612","authenticated-orcid":false,"given":"Dorinde M.","family":"van Andel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4441-1448","authenticated-orcid":false,"given":"Nicolaas P.A.","family":"Zuithoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0727-7451","authenticated-orcid":false,"given":"Mandy G.","family":"Keijzer-Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelien J.A.","family":"Schulp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floortje E.","family":"Scheepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8956-0324","authenticated-orcid":false,"given":"Marc R.","family":"Lilien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8408-4800","authenticated-orcid":false,"given":"Bob","family":"Oranje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilgo","family":"Bruining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2020.07.888_bib1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2020.07.888_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamapsychiatry.2019.1956","article-title":"Temporal changes in effect sizes of studies comparing individuals with and without autism: a meta-analysis","volume":"76","author":"Rodgaard","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2020.07.888_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-publhealth-031816-044318","article-title":"The Changing epidemiology of autism spectrum disorders","volume":"38","author":"Lyall","year":"2017","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jaac.2020.07.888_bib4","first-page":"1","article-title":"Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey","volume":"87","author":"Zablotsky","year":"2015","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.jaac.2020.07.888_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00787-017-1020-0","article-title":"Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review","volume":"26","author":"Muskens","year":"2017","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2020.07.888_bib6","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1542\/peds.2011-0427","article-title":"A\u00a0systematic review of medical treatments for children with autism spectrum disorders","volume":"127","author":"McPheeters","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2020.07.888_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nm.4071","article-title":"Advancing the understanding of autism disease mechanisms through genetics","volume":"22","author":"de la Torre-Ubieta","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jaac.2020.07.888_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fped.2014.00070","article-title":"GABAergic signaling as therapeutic target for autism spectrum disorders","volume":"2","author":"Cellot","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaac.2020.07.888_bib9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tins.2017.07.001","article-title":"NKCC1 Chloride importer antagonists attenuate many neurological and psychiatric disorders","volume":"40","author":"Ben-Ari","year":"2017","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jaac.2020.07.888_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neubiorev.2018.05.001","article-title":"Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions","volume":"90","author":"Schulte","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jaac.2020.07.888_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnins.2019.00310","article-title":"Off-label use of bumetanide for brain disorders: an overview","volume":"13","author":"Kharod","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jaac.2020.07.888_bib12","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/j.1651-2227.2010.01933.x","article-title":"The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects","volume":"99","author":"Lemonnier","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaac.2020.07.888_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.124","article-title":"A\u00a0randomised controlled trial of bumetanide in the treatment of autism in children","volume":"2","author":"Lemonnier","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jaac.2020.07.888_bib14","article-title":"Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders","volume":"7","author":"Lemonnier","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jaac.2020.07.888_bib15","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1111\/apa.12235","article-title":"Treating Fragile X syndrome with the diuretic bumetanide: a case report","volume":"102","author":"Lemonnier","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaac.2020.07.888_bib16","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1038\/s41598-018-21958-x","article-title":"Bumetanide for autism: more eye contact, less amygdala activation","volume":"8","author":"Hadjikhani","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaac.2020.07.888_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1362361313514141","article-title":"Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study","volume":"19","author":"Hadjikhani","year":"2015","journal-title":"Autism"},{"key":"10.1016\/j.jaac.2020.07.888_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13229-017-0146-8","article-title":"The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders","volume":"8","author":"Loth","year":"2017","journal-title":"Mol Autism"},{"key":"10.1016\/j.jaac.2020.07.888_bib19","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/npp.2016.237","article-title":"Arbaclofen in children and adolescents with autism spectrum disorder: a randomized, controlled, phase 2 trial","volume":"42","author":"Veenstra-VanderWeele","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jaac.2020.07.888_bib20","first-page":"373","article-title":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects","volume":"79","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaac.2020.07.888_bib21","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR)","year":"2000"},{"key":"10.1016\/j.jaac.2020.07.888_bib22","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","year":"2013"},{"key":"10.1016\/j.jaac.2020.07.888_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10803-006-0280-1","article-title":"The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity","volume":"37","author":"Gotham","year":"2007","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.jaac.2020.07.888_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1025014929212","article-title":"Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised","volume":"33","author":"Constantino","year":"2003","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.jaac.2020.07.888_bib25","article-title":"OxMaR: open source free software for online minimization and randomization for clinical trials","volume":"9","author":"O'Callaghan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaac.2020.07.888_bib26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1503\/cmaj.131353","article-title":"Randomized trials with missing outcome data: how to analyze and what to report","volume":"186","author":"Groenwold","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.jaac.2020.07.888_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/1745-6215-15-456","article-title":"Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials","volume":"15","author":"Kahan","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.jaac.2020.07.888_bib28","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jclinepi.2014.11.001","article-title":"Covariate adjustment had similar benefits in small and large randomized controlled trials","volume":"68","author":"Thompson","year":"2015","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaac.2020.07.888_bib29","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2004"},{"key":"10.1016\/j.jaac.2020.07.888_bib30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/1362361314542955","article-title":"Measuring social communication behaviors as\u00a0a\u00a0treatment endpoint in individuals with autism spectrum disorder","volume":"19","author":"Anagnostou","year":"2015","journal-title":"Autism"},{"key":"10.1016\/j.jaac.2020.07.888_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/cap.2015.0146","article-title":"Safety and efficacy of memantine in children with autism: randomized, placebo-controlled study and open-label extension","volume":"27","author":"Aman","year":"2017","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2020.07.888_bib32","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1073\/pnas.1705521114","article-title":"Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism","volume":"114","author":"Parker","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaac.2020.07.888_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0004867416652735","article-title":"A\u00a0randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder","volume":"51","author":"Dean","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.jaac.2020.07.888_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/scitranslmed.aau7356","article-title":"A\u00a0randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism","volume":"11","author":"Parker","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaac.2020.07.888_bib35","doi-asserted-by":"crossref","first-page":"e1124","DOI":"10.1038\/tp.2017.101","article-title":"Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders","volume":"7","author":"Lemonnier","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jaac.2020.07.888_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism","volume":"66","author":"King","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2020.07.888_bib37","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nrn1787","article-title":"Critical period plasticity in local cortical circuits","volume":"6","author":"Hensch","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jaac.2020.07.888_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13229-017-0145-9","article-title":"The EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation","volume":"8","author":"Charman","year":"2017","journal-title":"Mol Autism"},{"key":"10.1016\/j.jaac.2020.07.888_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fnins.2016.00268","article-title":"Toward an interdisciplinary understanding of sensory dysfunction in autism spectrum disorder: an integration of the neural and symptom literatures","volume":"10","author":"Schauder","year":"2016","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jaac.2020.07.888_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"Lord","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaac.2020.07.888_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41380-018-0056-y","article-title":"The ASD living biology: from cell proliferation to clinical phenotype","volume":"24","author":"Courchesne","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jaac.2020.07.888_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41386-019-0519-0","article-title":"Selection criteria for neurophysiologic biomarkers to accelerate the pace of CNS therapeutic development","volume":"45","author":"Light","year":"2020","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856720312909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856720312909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T18:58:42Z","timestamp":1721415522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856720312909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0890856720312909"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2020.07.888","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2020.07.888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92020 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}